Expanding TAVI to Low and Intermediate Risk Patients
TAVI has become the standard treatment in patients at increased surgical risk and is increasingly being performed in patients at intermediate to low surgical risk. While non-inferiority has been demonstrated in intermediate risk patients, several challenges—particularly with regard to valve durabili...
Main Authors: | Lisa Voigtländer, Moritz Seiffert |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcvm.2018.00092/full |
Similar Items
-
Aortic Stenosis Phenotypes and Precision Transcatheter Aortic Valve Implantation
by: Muzamil Khawaja, et al.
Published: (2023-06-01) -
Thoracic Aorta Perforation Treated Conservatively After TAVR in a Patient With Extremely Tortuous Aorta
by: Lisa Manevich, MD, et al.
Published: (2023-01-01) -
Editorial: Transcatheter Aortic Valve Implantation—Current Challenges and Future Directions
by: Richard J. Jabbour, et al.
Published: (2021-09-01) -
Early and late outcomes after transcatheter aortic valve implantation in Indian subpopulation
by: Ankur Agarwal, et al.
Published: (2022-09-01) -
TAVR for All? The Surgical Perspective
by: Xiling Zhang, et al.
Published: (2022-07-01)